Table 1.
Characteristics of patient medication review writers.
| Demographics | Total (n=1768), n (%) | |
| Gender |
|
|
|
|
Male | 214 (12.10) |
|
|
Female | 1485 (83.99) |
|
|
N/A | 69 (3.90) |
| Age, years |
|
|
|
|
13-44 | 562 (31.79) |
|
|
45-64 | 863 (48.81) |
|
|
65 and over | 306 (17.31) |
|
|
N/A | 37 (2.09) |
| Treatment duration, years |
|
|
|
|
Less than 1 | 772 (43.67) |
|
|
1-5 | 423 (23.93) |
|
|
More than 5 | 505 (28.56) |
|
|
N/A | 68 (3.85) |
| Reasons of taking levothyroxine |
|
|
|
|
Progressive disease of the thyroid gland | 56 (3.17) |
|
|
Additional treatment for thyroid cancer | 1 (0.06) |
|
|
Decreased thyroid function existing from birth | 20 (1.13) |
|
|
Enlarged thyroid gland | 42 (2.38) |
|
|
Myxedema coma | 1 (0.06) |
|
|
Serious decrease in thyroid function | 81 (4.58) |
|
|
Thyroid cancer | 115 (6.50) |
|
|
Underactive thyroid | 1300 (73.53) |
|
|
Other | 152 (8.60) |
| Reviewer type |
|
|
|
|
Caregiver | 27 (1.53) |
|
|
Patient | 1694 (95.81) |
|
|
N/A | 42 (2.66) |
| Year |
|
|
|
|
2007 | 73 (4.13) |
|
|
2008 | 210 (11.88) |
|
|
2009 | 351 (19.85) |
|
|
2010 | 321 (18.16) |
|
|
2011 | 234 (13.24) |
|
|
2012 | 178 (10.07) |
|
|
2013 | 197 (11.14) |
|
|
2014 | 107 (6.05) |
|
|
2015 | 39 (2.21) |
|
|
2016 | 54 (3.05) |
|
|
2017 | 4 (0.23) |